Home
>
National Drug Code (NDC)
>
ATACAND
ATACAND - 0186-0008-31 - (Candesartan cilexetil)
Drug Information of ATACAND
| Product NDC: | 0186-0008 |
| Proprietary Name: | ATACAND |
| Non Proprietary Name: | Candesartan cilexetil |
| Active Ingredient(s): | 8 mg/1 & nbsp; Candesartan cilexetil |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ATACAND
| Product NDC: | 0186-0008 |
| Labeler Name: | AstraZeneca LP |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020838 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19980914 |
Package Information of ATACAND
| Package NDC: | 0186-0008-31 |
| Package Description: | 30 TABLET in 1 BOTTLE (0186-0008-31) |
NDC Information of ATACAND
| NDC Code | 0186-0008-31 |
| Proprietary Name | ATACAND |
| Package Description | 30 TABLET in 1 BOTTLE (0186-0008-31) |
| Product NDC | 0186-0008 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Candesartan cilexetil |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19980914 |
| Marketing Category Name | NDA |
| Labeler Name | AstraZeneca LP |
| Substance Name | CANDESARTAN CILEXETIL |
| Strength Number | 8 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |
